MEDP: Medpace Holdings, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 6 sales totaling $59.31M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-09-30 | Troendle August J. | CEO | $13.74M | |
| 2026-09-29 | Troendle August J. | CEO | $16.58M | |
| 2026-09-28 | Troendle August J. | CEO | $1.49M | |
| 2026-09-25 | Troendle August J. | CEO | $96K | |
| 2026-09-24 | Troendle August J. | CEO | $17.29M | |
| 2026-09-23 | Troendle August J. | CEO | $10.11M |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-28 | 13D amendment | August J. Troendle | 19.10% | SEC | |
| 2026-08-14 | New 13G stake | T. Rowe Price Associates, Inc. | 7.20% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.